Is A’ja Wilson’s MVP-caliber WNBA season the greatest ever?
Michael Voepel, ESPN Senior WriterSep 17, 2024, 10:30 AM ET Close Michael Voepel is a senior writer who covers the WNBA, women’s college basketball and other college sports. Voepel began…
Latest & Upcoming Technology Updates
Michael Voepel, ESPN Senior WriterSep 17, 2024, 10:30 AM ET Close Michael Voepel is a senior writer who covers the WNBA, women’s college basketball and other college sports. Voepel began…
London: EU antitrust regulators are set to fine world No. 1 generic drugmaker Teva in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone,…
Tim MacMahon, ESPN Staff WriterSep 17, 2024, 12:39 PM ET Close Joined ESPNDallas.com in September 2009 Covers the Dallas Cowboys and Dallas Mavericks Appears regularly on ESPN Dallas 103.3 FM…
Whether you’re focused on losing weight, maintaining your weight, or building muscle, diet plays a crucial role in your progress. Tracking your calories is a good place to start, but…
Sep 17, 2024, 09:09 AM ET The final week of the WNBA regular season is upon us, which means it’s time for voters — including the three of us —…
By Patrick Wingrove London: UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of…
Marcel Louis-Jacques, ESPNSep 17, 2024, 04:10 PM ET Close Marcel Louis-Jacques joined ESPN in 2019 as a beat reporter covering the Buffalo Bills, before switching to the Miami Dolphins in…
By Mariam Sunny London: Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become…
Katherine Terrell, ESPN Staff WriterSep 17, 2024, 06:00 AM ET Close Katherine Terrell came back to ESPN to cover the New Orleans Saints in the summer of 2022. She left…
London: The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk and Eli Lilly, according…